3,171 reports of this reaction
1.2% of all EVOLOCUMAB reports
#18 most reported adverse reaction
MUSCLE SPASMS is the #18 most commonly reported adverse reaction for EVOLOCUMAB, manufactured by Amgen USA Inc.. There are 3,171 FDA adverse event reports linking EVOLOCUMAB to MUSCLE SPASMS. This represents approximately 1.2% of all 266,603 adverse event reports for this drug.
Patients taking EVOLOCUMAB who experience muscle spasms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MUSCLE SPASMS is a less commonly reported adverse event for EVOLOCUMAB, but still significant enough to appear in the safety profile.
In addition to muscle spasms, the following adverse reactions have been reported for EVOLOCUMAB:
The following drugs have also been linked to muscle spasms in FDA adverse event reports:
MUSCLE SPASMS has been reported as an adverse event in 3,171 FDA reports for EVOLOCUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
MUSCLE SPASMS accounts for approximately 1.2% of all adverse event reports for EVOLOCUMAB, making it a notable side effect.
If you experience muscle spasms while taking EVOLOCUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.